Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.

Pediatric rheumatology online journal - 1 Jan 2014

van Dijkhuizen E H Pieter, Wulffraat Nico M

Abstract excerpt

BACKGROUND: Methotrexate (MTX) is the cornerstone disease-modifying anti-rheumatic drug in juvenile idiopathic arthritis (JIA). In JIA, it is important to start effective treatment early to avoid long-term sequelae, such as joint damage. To accomplish this goal, it is crucial to know beforehand w...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antinuclear
Share to Antirheumatic Agents
Share to Arthritis, Juvenile

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ATP-Binding Cassette Transporters

Share to Biomarkers

Share to Methotrexate

Share to Predictive Value of Tests

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 25525416
DOI: 10.1186/1546-0096-12-51
PMCID: PMC4269851

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25525416-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.PMID 25525416Read ↗

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis.Semantic proximity Read ↗

Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.Semantic proximity Read ↗

In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?Semantic proximity Read ↗

The impact of single nucleotide polymorphisms in ADORA2A and ADORA3 genes on the early response to methotrexate and presence of therapy side effects in children with juvenile idiopathic arthritis: Results of a preliminary study.Semantic proximity Read ↗

Associations between gene polymorphisms and treatment outcomes of methotrexate in patients with juvenile idiopathic arthritis.Semantic proximity Read ↗

Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis.Semantic proximity Read ↗

SLCO1B1 variants as predictors of methotrexate-related toxicity in children with juvenile idiopathic arthritis.Semantic proximity Read ↗

Using pharmacogenetics to predict methotrexate response in rheumatoid arthritis patients.Semantic proximity Read ↗

Relationship between SLCO1B1 polymorphisms and methotrexate intolerance in Mexican children with juvenile idiopathic arthritis.Semantic proximity Read ↗

The pharmacogenetics of methotrexateSemantic proximity Read ↗

Methotrexate pharmacogenetics in rheumatoid arthritis: a status report.Semantic proximity Read ↗

The relationship of the immune response mediator genes’ polymorphic variants with the methotrexate efficacy in juvenile idiopathic arthritisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.